1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 29, 2001
-------------------------------
Response Oncology, Inc.
----------------------------
(Exact name of registrant as specified in its charter)
State of Tennessee 0-15416 62-1212264
- ------------------------------- ----------- -------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File No.) Identification No.)
1805 Moriah Woods Blvd.
Memphis, Tennessee 38117
- ------------------------------- ---------
(Address of Principal Executive (Zip Code)
Offices)
(901) 761-7000
- -------------------------------
(Registrant's telephone number,
including area code)
2
Item 3. Bankruptcy or Receivership.
On March 29, 2001, Response Oncology, Inc. (the "Company") and its wholly owned
subsidiaries (Response Oncology Management of South Florida, Inc., Response
Oncology of Fort Lauderdale, Inc. and Response Oncology of Tamarac, Inc.) filed
voluntary petitions for relief under Chapter 11 of the United States Bankruptcy
Code in the United States Bankruptcy Court for the Western District of
Tennessee. The case number is 01-24607-DSK.
A copy of the press release dated March 30, 2001 relating to the filing of the
petitions with the Bankruptcy Court are attached to this Current Report on Form
8-K as Exhibit 99.1 and is incorporated herein in its entirety by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
99.1 Press Release dated March 30, 2001
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Response Oncology, Inc.
By:
/s/ Peter A. Stark
Date: April 9, 2001 -----------------------------------------
Peter A. Stark, Executive Vice President,
Chief Financial Officer
3
EXHIBIT INDEX
Exhibit Number Description
99.1 Press release dated March 30, 2001